EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy

Panayotis K Vlachakis, Panagiotis Theofilis iD, Stergios Soulaidopoulos, Emilia Lazarou, Konstantinos Tsioufis iD, George Lazaros iD

Drug Design, Development and Therapy · 2024-09 · Volume 18 · 3939-3950

DOI: 10.2147/dddt.s261119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-09. Verfasst von Panayotis K Vlachakis und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece. Hauptthemen laut MEDLINE: Pericarditis, Recombinant Fusion Proteins, Recurrence. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericarditisRecombinant Fusion ProteinsRecurrenceHumansDrug DesignDrug DevelopmentInterleukin-1

Stichwörter der Autor:innen

NLRP3 inflammasomeinterleukin-1 blockersrecurrent pericarditisrilonacept

Substanzen

rilonaceptRecombinant Fusion ProteinsInterleukin-1

Autor:innen und Institutionen

  • First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece.

ORCID-Profile: Panagiotis Theofilis, Konstantinos Tsioufis, George Lazaros

Zitieren

APA

Vlachakis, P. K., Theofilis, P., Soulaidopoulos, S., Lazarou, E., Tsioufis, K., & Lazaros, G. (2024). Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy. Drug Design, Development and Therapy, Volume 18, 3939-3950. https://doi.org/10.2147/dddt.s261119

Vancouver

Vlachakis PK, Theofilis P, Soulaidopoulos S, Lazarou E, Tsioufis K, Lazaros G. Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy. Drug Design, Development and Therapy. 2024;Volume 18:3939-3950. doi:10.2147/dddt.s261119

BibTeX
@article{Vlachakis2024,
  author = {Vlachakis, Panayotis K and Theofilis, Panagiotis and Soulaidopoulos, Stergios and Lazarou, Emilia and Tsioufis, Konstantinos and Lazaros, George},
  title = {Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {3939--3950},
  doi = {10.2147/dddt.s261119}
}
Kostenlos starten →